1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Gene Therapy on Neurological Diseases Market Size 2017-2028 2.1.2 Gene Therapy on Neurological Diseases Market Size CAGR by Region 2017 VS 2022 VS 2028 2.2 Gene Therapy on Neurological Diseases Segment by Type 2.2.1 Viral Gene Therapy 2.2.2 Non-viral Gene Therapy 2.3 Gene Therapy on Neurological Diseases Market Size by Type 2.3.1 Gene Therapy on Neurological Diseases Market Size CAGR by Type (2017 VS 2022 VS 2028) 2.3.2 Global Gene Therapy on Neurological Diseases Market Size Market Share by Type (2017-2022) 2.4 Gene Therapy on Neurological Diseases Segment by Application 2.4.1 Hospital 2.4.2 Clinic 2.4.3 Other 2.5 Gene Therapy on Neurological Diseases Market Size by Application 2.5.1 Gene Therapy on Neurological Diseases Market Size CAGR by Application (2017 VS 2022 VS 2028) 2.5.2 Global Gene Therapy on Neurological Diseases Market Size Market Share by Application (2017-2022) 3 Gene Therapy on Neurological Diseases Market Size by Player 3.1 Gene Therapy on Neurological Diseases Market Size Market Share by Players 3.1.1 Global Gene Therapy on Neurological Diseases Revenue by Players (2020-2022) 3.1.2 Global Gene Therapy on Neurological Diseases Revenue Market Share by Players (2020-2022) 3.2 Global Gene Therapy on Neurological Diseases Key Players Head office and Products Offered 3.3 Market Concentration Rate Analysis 3.3.1 Competition Landscape Analysis 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022) 3.4 New Products and Potential Entrants 3.5 Mergers & Acquisitions, Expansion 4 Gene Therapy on Neurological Diseases by Regions 4.1 Gene Therapy on Neurological Diseases Market Size by Regions (2017-2022) 4.2 Americas Gene Therapy on Neurological Diseases Market Size Growth (2017-2022) 4.3 APAC Gene Therapy on Neurological Diseases Market Size Growth (2017-2022) 4.4 Europe Gene Therapy on Neurological Diseases Market Size Growth (2017-2022) 4.5 Middle East & Africa Gene Therapy on Neurological Diseases Market Size Growth (2017-2022) 5 Americas 5.1 Americas Gene Therapy on Neurological Diseases Market Size by Country (2017-2022) 5.2 Americas Gene Therapy on Neurological Diseases Market Size by Type (2017-2022) 5.3 Americas Gene Therapy on Neurological Diseases Market Size by Application (2017-2022) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Gene Therapy on Neurological Diseases Market Size by Region (2017-2022) 6.2 APAC Gene Therapy on Neurological Diseases Market Size by Type (2017-2022) 6.3 APAC Gene Therapy on Neurological Diseases Market Size by Application (2017-2022) 6.4 China 6.5 Japan 6.6 Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 7 Europe 7.1 Europe Gene Therapy on Neurological Diseases by Country (2017-2022) 7.2 Europe Gene Therapy on Neurological Diseases Market Size by Type (2017-2022) 7.3 Europe Gene Therapy on Neurological Diseases Market Size by Application (2017-2022) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Gene Therapy on Neurological Diseases by Region (2017-2022) 8.2 Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Type (2017-2022) 8.3 Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Application (2017-2022) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Global Gene Therapy on Neurological Diseases Market Forecast 10.1 Global Gene Therapy on Neurological Diseases Forecast by Regions (2023-2028) 10.1.1 Global Gene Therapy on Neurological Diseases Forecast by Regions (2023-2028) 10.1.2 Americas Gene Therapy on Neurological Diseases Forecast 10.1.3 APAC Gene Therapy on Neurological Diseases Forecast 10.1.4 Europe Gene Therapy on Neurological Diseases Forecast 10.1.5 Middle East & Africa Gene Therapy on Neurological Diseases Forecast 10.2 Americas Gene Therapy on Neurological Diseases Forecast by Country (2023-2028) 10.2.1 United States Gene Therapy on Neurological Diseases Market Forecast 10.2.2 Canada Gene Therapy on Neurological Diseases Market Forecast 10.2.3 Mexico Gene Therapy on Neurological Diseases Market Forecast 10.2.4 Brazil Gene Therapy on Neurological Diseases Market Forecast 10.3 APAC Gene Therapy on Neurological Diseases Forecast by Region (2023-2028) 10.3.1 China Gene Therapy on Neurological Diseases Market Forecast 10.3.2 Japan Gene Therapy on Neurological Diseases Market Forecast 10.3.3 Korea Gene Therapy on Neurological Diseases Market Forecast 10.3.4 Southeast Asia Gene Therapy on Neurological Diseases Market Forecast 10.3.5 India Gene Therapy on Neurological Diseases Market Forecast 10.3.6 Australia Gene Therapy on Neurological Diseases Market Forecast 10.4 Europe Gene Therapy on Neurological Diseases Forecast by Country (2023-2028) 10.4.1 Germany Gene Therapy on Neurological Diseases Market Forecast 10.4.2 France Gene Therapy on Neurological Diseases Market Forecast 10.4.3 UK Gene Therapy on Neurological Diseases Market Forecast 10.4.4 Italy Gene Therapy on Neurological Diseases Market Forecast 10.4.5 Russia Gene Therapy on Neurological Diseases Market Forecast 10.5 Middle East & Africa Gene Therapy on Neurological Diseases Forecast by Region (2023-2028) 10.5.1 Egypt Gene Therapy on Neurological Diseases Market Forecast 10.5.2 South Africa Gene Therapy on Neurological Diseases Market Forecast 10.5.3 Israel Gene Therapy on Neurological Diseases Market Forecast 10.5.4 Turkey Gene Therapy on Neurological Diseases Market Forecast 10.5.5 GCC Countries Gene Therapy on Neurological Diseases Market Forecast 10.6 Global Gene Therapy on Neurological Diseases Forecast by Type (2023-2028) 10.7 Global Gene Therapy on Neurological Diseases Forecast by Application (2023-2028) 11 Key Players Analysis 11.1 Biogen 11.1.1 Biogen Company Information 11.1.2 Biogen Gene Therapy on Neurological Diseases Product Offered 11.1.3 Biogen Gene Therapy on Neurological Diseases Revenue, Gross Margin and Market Share (2020-2022) 11.1.4 Biogen Main Business Overview 11.1.5 Biogen Latest Developments 11.2 Novartis 11.2.1 Novartis Company Information 11.2.2 Novartis Gene Therapy on Neurological Diseases Product Offered 11.2.3 Novartis Gene Therapy on Neurological Diseases Revenue, Gross Margin and Market Share (2020-2022) 11.2.4 Novartis Main Business Overview 11.2.5 Novartis Latest Developments 11.3 Sarepta Therapeutics 11.3.1 Sarepta Therapeutics Company Information 11.3.2 Sarepta Therapeutics Gene Therapy on Neurological Diseases Product Offered 11.3.3 Sarepta Therapeutics Gene Therapy on Neurological Diseases Revenue, Gross Margin and Market Share (2020-2022) 11.3.4 Sarepta Therapeutics Main Business Overview 11.3.5 Sarepta Therapeutics Latest Developments 12 Research Findings and Conclusion

List of Tables Table 1. Gene Therapy on Neurological Diseases Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions) Table 2. Major Players of Viral Gene Therapy Table 3. Major Players of Non-viral Gene Therapy Table 4. Gene Therapy on Neurological Diseases Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions) Table 5. Global Gene Therapy on Neurological Diseases Market Size by Type (2017-2022) & ($ Millions) Table 6. Global Gene Therapy on Neurological Diseases Market Size Market Share by Type (2017-2022) Table 7. Gene Therapy on Neurological Diseases Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions) Table 8. Global Gene Therapy on Neurological Diseases Market Size by Application (2017-2022) & ($ Millions) Table 9. Global Gene Therapy on Neurological Diseases Market Size Market Share by Application (2017-2022) Table 10. Global Gene Therapy on Neurological Diseases Revenue by Players (2020-2022) & ($ Millions) Table 11. Global Gene Therapy on Neurological Diseases Revenue Market Share by Player (2020-2022) Table 12. Gene Therapy on Neurological Diseases Key Players Head office and Products Offered Table 13. Gene Therapy on Neurological Diseases Concentration Ratio (CR3, CR5 and CR10) & (2020-2022) Table 14. New Products and Potential Entrants Table 15. Mergers & Acquisitions, Expansion Table 16. Global Gene Therapy on Neurological Diseases Market Size by Regions 2017-2022 & ($ Millions) Table 17. Global Gene Therapy on Neurological Diseases Market Size Market Share by Regions (2017-2022) Table 18. Americas Gene Therapy on Neurological Diseases Market Size by Country (2017-2022) & ($ Millions) Table 19. Americas Gene Therapy on Neurological Diseases Market Size Market Share by Country (2017-2022) Table 20. Americas Gene Therapy on Neurological Diseases Market Size by Type (2017-2022) & ($ Millions) Table 21. Americas Gene Therapy on Neurological Diseases Market Size Market Share by Type (2017-2022) Table 22. Americas Gene Therapy on Neurological Diseases Market Size by Application (2017-2022) & ($ Millions) Table 23. Americas Gene Therapy on Neurological Diseases Market Size Market Share by Application (2017-2022) Table 24. APAC Gene Therapy on Neurological Diseases Market Size by Region (2017-2022) & ($ Millions) Table 25. APAC Gene Therapy on Neurological Diseases Market Size Market Share by Region (2017-2022) Table 26. APAC Gene Therapy on Neurological Diseases Market Size by Type (2017-2022) & ($ Millions) Table 27. APAC Gene Therapy on Neurological Diseases Market Size Market Share by Type (2017-2022) Table 28. APAC Gene Therapy on Neurological Diseases Market Size by Application (2017-2022) & ($ Millions) Table 29. APAC Gene Therapy on Neurological Diseases Market Size Market Share by Application (2017-2022) Table 30. Europe Gene Therapy on Neurological Diseases Market Size by Country (2017-2022) & ($ Millions) Table 31. Europe Gene Therapy on Neurological Diseases Market Size Market Share by Country (2017-2022) Table 32. Europe Gene Therapy on Neurological Diseases Market Size by Type (2017-2022) & ($ Millions) Table 33. Europe Gene Therapy on Neurological Diseases Market Size Market Share by Type (2017-2022) Table 34. Europe Gene Therapy on Neurological Diseases Market Size by Application (2017-2022) & ($ Millions) Table 35. Europe Gene Therapy on Neurological Diseases Market Size Market Share by Application (2017-2022) Table 36. Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Region (2017-2022) & ($ Millions) Table 37. Middle East & Africa Gene Therapy on Neurological Diseases Market Size Market Share by Region (2017-2022) Table 38. Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Type (2017-2022) & ($ Millions) Table 39. Middle East & Africa Gene Therapy on Neurological Diseases Market Size Market Share by Type (2017-2022) Table 40. Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Application (2017-2022) & ($ Millions) Table 41. Middle East & Africa Gene Therapy on Neurological Diseases Market Size Market Share by Application (2017-2022) Table 42. Key Market Drivers & Growth Opportunities of Gene Therapy on Neurological Diseases Table 43. Key Market Challenges & Risks of Gene Therapy on Neurological Diseases Table 44. Key Industry Trends of Gene Therapy on Neurological Diseases Table 45. Global Gene Therapy on Neurological Diseases Market Size Forecast by Regions (2023-2028) & ($ Millions) Table 46. Global Gene Therapy on Neurological Diseases Market Size Market Share Forecast by Regions (2023-2028) Table 47. Global Gene Therapy on Neurological Diseases Market Size Forecast by Type (2023-2028) & ($ Millions) Table 48. Global Gene Therapy on Neurological Diseases Market Size Market Share Forecast by Type (2023-2028) Table 49. Global Gene Therapy on Neurological Diseases Market Size Forecast by Application (2023-2028) & ($ Millions) Table 50. Global Gene Therapy on Neurological Diseases Market Size Market Share Forecast by Application (2023-2028) Table 51. Biogen Details, Company Type, Gene Therapy on Neurological Diseases Area Served and Its Competitors Table 52. Biogen Gene Therapy on Neurological Diseases Product Offered Table 53. Biogen Gene Therapy on Neurological Diseases Revenue ($ million), Gross Margin and Market Share (2020-2022) Table 54. Biogen Main Business Table 55. Biogen Latest Developments Table 56. Novartis Details, Company Type, Gene Therapy on Neurological Diseases Area Served and Its Competitors Table 57. Novartis Gene Therapy on Neurological Diseases Product Offered Table 58. Novartis Main Business Table 59. Novartis Gene Therapy on Neurological Diseases Revenue ($ million), Gross Margin and Market Share (2020-2022) Table 60. Novartis Latest Developments Table 61. Sarepta Therapeutics Details, Company Type, Gene Therapy on Neurological Diseases Area Served and Its Competitors Table 62. Sarepta Therapeutics Gene Therapy on Neurological Diseases Product Offered Table 63. Sarepta Therapeutics Main Business Table 64. Sarepta Therapeutics Gene Therapy on Neurological Diseases Revenue ($ million), Gross Margin and Market Share (2020-2022) Table 65. Sarepta Therapeutics Latest Developments List of Figures Figure 1. Gene Therapy on Neurological Diseases Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Gene Therapy on Neurological Diseases Market Size Growth Rate 2017-2028 ($ Millions) Figure 6. Global Gene Therapy on Neurological Diseases Market Size Market Share by Type in 2021 Figure 7. Gene Therapy on Neurological Diseases in Hospital Figure 8. Global Gene Therapy on Neurological Diseases Market: Hospital (2017-2022) & ($ Millions) Figure 9. Gene Therapy on Neurological Diseases in Clinic Figure 10. Global Gene Therapy on Neurological Diseases Market: Clinic (2017-2022) & ($ Millions) Figure 11. Gene Therapy on Neurological Diseases in Other Figure 12. Global Gene Therapy on Neurological Diseases Market: Other (2017-2022) & ($ Millions) Figure 13. Global Gene Therapy on Neurological Diseases Market Size Market Share by Application in 2021 Figure 14. Global Gene Therapy on Neurological Diseases Revenue Market Share by Player in 2021 Figure 15. Global Gene Therapy on Neurological Diseases Market Size Market Share by Regions (2017-2022) Figure 16. Americas Gene Therapy on Neurological Diseases Market Size 2017-2022 ($ Millions) Figure 17. APAC Gene Therapy on Neurological Diseases Market Size 2017-2022 ($ Millions) Figure 18. Europe Gene Therapy on Neurological Diseases Market Size 2017-2022 ($ Millions) Figure 19. Middle East & Africa Gene Therapy on Neurological Diseases Market Size 2017-2022 ($ Millions) Figure 20. Americas Gene Therapy on Neurological Diseases Value Market Share by Country in 2021 Figure 21. Americas Gene Therapy on Neurological Diseases Consumption Market Share by Type in 2021 Figure 22. Americas Gene Therapy on Neurological Diseases Market Size Market Share by Application in 2021 Figure 23. United States Gene Therapy on Neurological Diseases Market Size Growth 2017-2022 ($ Millions) Figure 24. Canada Gene Therapy on Neurological Diseases Market Size Growth 2017-2022 ($ Millions) Figure 25. Mexico Gene Therapy on Neurological Diseases Market Size Growth 2017-2022 ($ Millions) Figure 26. Brazil Gene Therapy on Neurological Diseases Market Size Growth 2017-2022 ($ Millions) Figure 27. APAC Gene Therapy on Neurological Diseases Market Size Market Share by Region in 2021 Figure 28. APAC Gene Therapy on Neurological Diseases Market Size Market Share by Application in 2021 Figure 29. China Gene Therapy on Neurological Diseases Market Size Growth 2017-2022 ($ Millions) Figure 30. Japan Gene Therapy on Neurological Diseases Market Size Growth 2017-2022 ($ Millions) Figure 31. Korea Gene Therapy on Neurological Diseases Market Size Growth 2017-2022 ($ Millions) Figure 32. Southeast Asia Gene Therapy on Neurological Diseases Market Size Growth 2017-2022 ($ Millions) Figure 33. India Gene Therapy on Neurological Diseases Market Size Growth 2017-2022 ($ Millions) Figure 34. Australia Gene Therapy on Neurological Diseases Market Size Growth 2017-2022 ($ Millions) Figure 35. Europe Gene Therapy on Neurological Diseases Market Size Market Share by Country in 2021 Figure 36. Europe Gene Therapy on Neurological Diseases Market Size Market Share by Type in 2021 Figure 37. Europe Gene Therapy on Neurological Diseases Market Size Market Share by Application in 2021 Figure 38. Germany Gene Therapy on Neurological Diseases Market Size Growth 2017-2022 ($ Millions) Figure 39. France Gene Therapy on Neurological Diseases Market Size Growth 2017-2022 ($ Millions) Figure 40. UK Gene Therapy on Neurological Diseases Market Size Growth 2017-2022 ($ Millions) Figure 41. Italy Gene Therapy on Neurological Diseases Market Size Growth 2017-2022 ($ Millions) Figure 42. Russia Gene Therapy on Neurological Diseases Market Size Growth 2017-2022 ($ Millions) Figure 43. Middle East & Africa Gene Therapy on Neurological Diseases Market Size Market Share by Region in 2021 Figure 44. Middle East & Africa Gene Therapy on Neurological Diseases Market Size Market Share by Type in 2021 Figure 45. Middle East & Africa Gene Therapy on Neurological Diseases Market Size Market Share by Application in 2021 Figure 46. Egypt Gene Therapy on Neurological Diseases Market Size Growth 2017-2022 ($ Millions) Figure 47. South Africa Gene Therapy on Neurological Diseases Market Size Growth 2017-2022 ($ Millions) Figure 48. Israel Gene Therapy on Neurological Diseases Market Size Growth 2017-2022 ($ Millions) Figure 49. Turkey Gene Therapy on Neurological Diseases Market Size Growth 2017-2022 ($ Millions) Figure 50. GCC Country Gene Therapy on Neurological Diseases Market Size Growth 2017-2022 ($ Millions) Figure 51. Americas Gene Therapy on Neurological Diseases Market Size 2023-2028 ($ Millions) Figure 52. APAC Gene Therapy on Neurological Diseases Market Size 2023-2028 ($ Millions) Figure 53. Europe Gene Therapy on Neurological Diseases Market Size 2023-2028 ($ Millions) Figure 54. Middle East & Africa Gene Therapy on Neurological Diseases Market Size 2023-2028 ($ Millions) Figure 55. United States Gene Therapy on Neurological Diseases Market Size 2023-2028 ($ Millions) Figure 56. Canada Gene Therapy on Neurological Diseases Market Size 2023-2028 ($ Millions) Figure 57. Mexico Gene Therapy on Neurological Diseases Market Size 2023-2028 ($ Millions) Figure 58. Brazil Gene Therapy on Neurological Diseases Market Size 2023-2028 ($ Millions) Figure 59. China Gene Therapy on Neurological Diseases Market Size 2023-2028 ($ Millions) Figure 60. Japan Gene Therapy on Neurological Diseases Market Size 2023-2028 ($ Millions) Figure 61. Korea Gene Therapy on Neurological Diseases Market Size 2023-2028 ($ Millions) Figure 62. Southeast Asia Gene Therapy on Neurological Diseases Market Size 2023-2028 ($ Millions) Figure 63. India Gene Therapy on Neurological Diseases Market Size 2023-2028 ($ Millions) Figure 64. Australia Gene Therapy on Neurological Diseases Market Size 2023-2028 ($ Millions) Figure 65. Germany Gene Therapy on Neurological Diseases Market Size 2023-2028 ($ Millions) Figure 66. France Gene Therapy on Neurological Diseases Market Size 2023-2028 ($ Millions) Figure 67. UK Gene Therapy on Neurological Diseases Market Size 2023-2028 ($ Millions) Figure 68. Italy Gene Therapy on Neurological Diseases Market Size 2023-2028 ($ Millions) Figure 69. Russia Gene Therapy on Neurological Diseases Market Size 2023-2028 ($ Millions) Figure 70. Spain Gene Therapy on Neurological Diseases Market Size 2023-2028 ($ Millions) Figure 71. Egypt Gene Therapy on Neurological Diseases Market Size 2023-2028 ($ Millions) Figure 72. South Africa Gene Therapy on Neurological Diseases Market Size 2023-2028 ($ Millions) Figure 73. Israel Gene Therapy on Neurological Diseases Market Size 2023-2028 ($ Millions) Figure 74. Turkey Gene Therapy on Neurological Diseases Market Size 2023-2028 ($ Millions) Figure 75. GCC Countries Gene Therapy on Neurological Diseases Market Size 2023-2028 ($ Millions)